| Bid Price | 8.00p | High Price | 8.21p |
|---|
| Ask Price | 9.00p | Low Price | 8.21p |
|---|
| Open Price | 8.50p | Spread | 11.11% |
|---|
| Prev Close | 8.50p | Volume | 150,000 |
|---|
Ondine Biomedical Inc. Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Dec 24, 2024 | 8.50 | 8.21 | 8.21 | 8.50 | 150,000 |
| Dec 23, 2024 | 8.50 | 9.00 | 8.21 | 8.50 | 66,990 |
| Dec 20, 2024 | 8.50 | 8.21 | 8.21 | 8.50 | 12,178 |
| Dec 19, 2024 | 8.13 | 9.00 | 7.75 | 8.50 | 808,016 |
| Dec 18, 2024 | 7.75 | 8.50 | 7.50 | 8.13 | 331,531 |
Ondine Biomedical Inc. Information
| Name | Ondine Biomedical Inc. | Index | FTSE AIM All Share |
|---|
| ISIN | CA68234M2058 | Epic | OBI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 15,000 | Trading Status | Closed |
|---|
| Shares in Issue | 426.23 m | Prev Close | 8.50p |
|---|
| PE Ratio | | Market Cap | £36.23 m |
|---|
| Div Yield | 0 | Div per Share | NaN CAD |
|---|
| EPS | -0.03 CAD | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -5.166889 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.804294 | Quick Ratio | 0.363455 |
|---|
Ondine Biomedical Inc. Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 22/11/24 | PLAC | Carolyn Cross | CEO | 18,710,100 @ £0.09 | £1,590,359.00 |
| 22/11/24 | PLAC | Margaret Shaw | NED | 197,186 @ £0.09 | £16,761.00 |
| 22/11/24 | PLAC | Junaid Bajwa | NED | 384,920 @ £0.09 | £32,718.00 |
| 22/11/24 | PLAC | Jean Duvall | NED | 419,912 @ £0.09 | £35,693.00 |
| 22/11/24 | PLAC | Michael Farrar | NED | 174,963 @ £0.09 | £14,872.00 |
| 11/11/24 | PLAC | Carolyn Cross | CEO | 1,305,188 @ £0.09 | £110,941.00 |
| 11/11/24 | PLAC | Margaret Shaw | NED | 197,661 @ £0.09 | £16,801.00 |
| 11/11/24 | PLAC | Junaid Bajwa | NED | 385,846 @ £0.09 | £32,797.00 |
| 11/11/24 | PLAC | Jean Duvall | NED | 420,923 @ £0.09 | £35,778.00 |
| 11/11/24 | PLAC | Michael Farrar | NED | 175,385 @ £0.09 | £14,908.00 |
Ondine Biomedical Inc. News
